Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study
Changfa Xia, Shangying Hu, Xiaoqian Xu, et al.
The Lancet Public Health (2019) Vol. 4, Iss. 9, pp. e462-e472
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation
Arnaud John Kombe Kombe, Bofeng Li, Ayesha Zahid, et al.
Frontiers in Public Health (2021) Vol. 8
Open Access | Times Cited: 438
Cancer burden in China: trends, risk factors and prevention
Dianqin Sun, He Li, Maomao Cao, et al.
Cancer Biology and Medicine (2020) Vol. 17, Iss. 4, pp. 879-895
Open Access | Times Cited: 194
Is it possible to halve the incidence of liver cancer in China by 2050?
Jufang Shi, Maomao Cao, Yuting Wang, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 5, pp. 1051-1065
Open Access | Times Cited: 129
Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis
Zhuoru Zou, Christopher K. Fairley, Jason J. Ong, et al.
The Lancet Global Health (2020) Vol. 8, Iss. 10, pp. e1335-e1344
Open Access | Times Cited: 124
Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China
Mingwang Shen, Zhuoru Zou, Heling Bao, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 34, pp. 100726-100726
Open Access | Times Cited: 22
Strategies to eliminate cervical cancer in China
Lü Ji, Manli Chen, Lan Yao
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 22
Incidence and Mortality of Cancers in Female Genital Organs — China, 2022
Kexin Sun, Bingfeng Han, Hongmei Zeng, et al.
Deleted Journal (2024) Vol. 6, Iss. 10, pp. 195-202
Open Access | Times Cited: 11
Women’s cancers in China: a spatio-temporal epidemiology analysis
Rongxin He, Bin Zhu, Jinlin Liu, et al.
BMC Women s Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 45
Achieving cervical cancer elimination among Indigenous women
Lisa J. Whop, Megan A. Smith, Tamara Butler, et al.
Preventive Medicine (2021) Vol. 144, pp. 106314-106314
Open Access | Times Cited: 44
Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the Global Burden of Disease
Meng Yang, Juan Du, Hui Lü, et al.
BMJ Open (2022) Vol. 12, Iss. 7, pp. e055470-e055470
Open Access | Times Cited: 35
Prevention Strategies and Early Diagnosis of Cervical Cancer: Current State and Prospects
В. В. Какоткин, Е. В. Семина, T.G. Zadorkina, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 610-610
Open Access | Times Cited: 17
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
Changfa Xia, Xiaoqian Xu, Xuelian Zhao, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 34
Sustainable Construction Investment, Real Estate Development, and COVID-19: A Review of Literature in the Field
Artūras Kaklauskas, Edmundas Kazimieras Zavadskas, Natalija Lepkova, et al.
Sustainability (2021) Vol. 13, Iss. 13, pp. 7420-7420
Open Access | Times Cited: 33
Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study
Meng Gao, Shangying Hu, Xuelian Zhao, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 36, pp. 100768-100768
Open Access | Times Cited: 15
Burden of female‐specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021
Wenhui Ren, Xiangyu Guo, Zheng Liu, et al.
Cancer (2025) Vol. 131, Iss. 2
Open Access
Efficacy and safety of photodynamic therapy mediatied by 5-aminolevulinic acid for the treatment of cervical intraepithelial neoplasia 3(CIN 3): A single-center, prospective, cohort study
Qin Han, Tongxia Wang, Zhangxin Wu, et al.
Photodiagnosis and Photodynamic Therapy (2025), pp. 104573-104573
Open Access
Influences of HPV disease perceptions, vaccine accessibility, and information exposure on social media on HPV vaccination uptake among 11,678 mothers with daughters aged 9–17 years in China: a cross-sectional study
Zian Lin, Siyu Chen, Lixian Su, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Trends in Incidence Rates, Mortality Rates, and Age-Period-Cohort Effects of Cervical Cancer — China, 2003–2017
Kexin Sun, Rongshou Zheng, Lin Lei, et al.
China CDC Weekly (2022) Vol. 4, Iss. 48, pp. 1070-1076
Open Access | Times Cited: 17
Knowledge, attitude, and perception regarding HPV-related diseases and vaccination among the general public in Guizhou Province of China
Luhong Xie, Ji Ren, Shaoju Min, et al.
Vaccine (2023) Vol. 41, Iss. 5, pp. 1119-1131
Open Access | Times Cited: 9
Cervical cancer screening aided by artificial intelligence, China
Xingce Zhu, Qiang Yao, Wei Dai, et al.
Bulletin of the World Health Organization (2023) Vol. 101, Iss. 06, pp. 381-390
Open Access | Times Cited: 9
Projected Time for the Elimination of Cervical Cancer Under Various Intervention Scenarios: Age-Period-Cohort Macrosimulation Study
Yi‐Chu Chen, Yun‐Yuan Chen, Shih‐Yung Su, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e46360-e46360
Open Access | Times Cited: 3
Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: a modelling study
Tingting You, Xuelian Zhao, Shangying Hu, et al.
EClinicalMedicine (2022) Vol. 56, pp. 101789-101789
Open Access | Times Cited: 12
Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study
Xuelian Zhao, Shuang Zhao, Changfa Xia, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9–14-year-old and 18–26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial
Juan Li, Shi Liwei, Ke Li, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7212-7219
Open Access | Times Cited: 7
Informing HPV vaccine pricing for government-funded vaccination in mainland China: a modelling study
Tingting You, Xuelian Zhao, Chenghao Pan, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 52, pp. 101209-101209
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top